May 15, 2025

Featuring perspectives from Dr Emmanuel S Antonarakis and Prof Karim Fizazi, including the following topics:

• Introduction: Quality of Life (0:00)
• PARP Inhibition (PARPi) (7:15)
• M0 Disease (23:18)
• Metastatic Hormone-Sensitive Prostate Cancer (34:33)
• Radiopharmaceuticals (46:16)
• Other Novel Investigational Approaches for...

May 14, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 2: Other Available and Emerging Therapeutic Approaches — Emmanuel S Antonarakis, MD

CME information and select...

May 13, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer (PC) — Professor Karim Fizazi, MD, PhD

CME information and select...

May 12, 2025

Featuring perspectives from Dr Christopher Flower and Dr Krish Patel, including the following topics:

• Role of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Non-Hodgkin Lymphoma (NHL) — Dr Patel (0:00)
• Other Available and Emerging Novel Therapies for NHL — Dr Flowers (22:07)

CME information...

May 11, 2025

Featuring perspectives from Dr David M O’Malley and Dr Brian M Slomovitz, including the following topics:

• Ovarian Cancer; HER2-Directed Therapy for Advanced Gynecologic Cancers — Dr O'Malley (0:00)
• Endometrial Cancer and Cervical Cancer — Dr Slomovitz (23:38)

CME information and select...